Relay Therapeutics (RLAY)
Relay Therapeutics Reports Second Quarter 2025 Financial Results and Corporate Updates
NextCure Inc (NXTC)
NextCure Provides Business Update and Reports Second Quarter 2025 Financial Results
Alector Inc (ALEC)
Alector Reports Second Quarter 2025 FinancialResults and Provides Business Update
Regeneron Pharmaceuticals Inc (REGN)
Regeneron Announces Investor Conference Presentations
Pacific Biosciences of California Inc (PACB)
PacBio Announces Second Quarter 2025 Financial Results
Zymeworks Inc (ZYME)
Zymeworks Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Eton Pharmaceuticals Inc. (ETON)
Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results
ICU Medical Inc (ICUI)
ICU Medical Announces Second Quarter 2025 Results and Updates its Fiscal Year 2025 Guidance
SenesTech Inc (SNES)
SenesTech Reports Second Quarter 2025 Financial Results with Record Revenue and Record Gross Profit Margins
Atea Pharmaceuticals Inc (AVIR)
Atea Pharmaceuticals Reports Second Quarter 2025 Financial Results and Provides Business Update
Pliant Therapeutics Inc (PLRX)
Pliant Therapeutics Provides Corporate Update and Reports Second Quarter 2025 Financial Results
Avadel Pharmaceuticals (AVDL)
Avadel Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
89bio Inc (ETNB)
89bio Reports Second Quarter 2025 Financial Results and Corporate Updates
Organogenesis Holdings Inc. (ORGO)
Organogenesis Holdings Inc. Reports Second Quarter 2025 Financial Results
Artivion Inc (AORT)
Artivion Reports Second Quarter 2025 Financial Results